EUVIMEDEUVIMED entdecken
Crossref

Anticancer Potential of Ligustilide Derived from Extract of Angelica sinensis against Colon Cancer: In vitro and Computer Molecular Docking Studies

Heng Li

Indian Journal of Pharmaceutical Education and Research · 23.10.2026 · 61 (1) · 127-136

DOI: 10.5530/ijper.20274023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.10.2026. Verfasst von Heng Li.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, H. (2026). Anticancer Potential of Ligustilide Derived from Extract of Angelica sinensis against Colon Cancer: In vitro and Computer Molecular Docking Studies. Indian Journal of Pharmaceutical Education and Research, 61(1), 127-136. https://doi.org/10.5530/ijper.20274023

Vancouver

Li H. Anticancer Potential of Ligustilide Derived from Extract of Angelica sinensis against Colon Cancer: In vitro and Computer Molecular Docking Studies. Indian Journal of Pharmaceutical Education and Research. 2026;61(1):127-136. doi:10.5530/ijper.20274023

BibTeX
@article{Li2026,
  author = {Li, Heng},
  title = {Anticancer Potential of Ligustilide Derived from Extract of Angelica sinensis against Colon Cancer: In vitro and Computer Molecular Docking Studies},
  journal = {Indian Journal of Pharmaceutical Education and Research},
  year = {2026},
  volume = {61},
  number = {1},
  pages = {127--136},
  doi = {10.5530/ijper.20274023}
}
Kostenlos starten →